| Literature DB >> 28636400 |
Yuvraj Singh1, K K Durga Rao Viswanadham1, Arun Kumar Jajoriya2, Jaya Gopal Meher1, Kavit Raval1, Swati Jaiswal3, Jayant Dewangan4, H K Bora5, Srikanta Kumar Rath4, Jawahar Lal3, Durga Prasad Mishra2, Manish K Chourasia1.
Abstract
PLGA was functionalized with PEG and biotin using click chemistry to generate a biotin receptor targeted copolymer (biotinylated-PEG-PLGA) which in turn was used to fabricate ultrafine nanoparticles (BPNP) of doxorubicin hydrochloride (DOX) for effective delivery in 4T1 cell induced breast cancer. However, adequate entrapment of a hydrophilic bioactive like DOX in a hydrophobic polymer system made of PLGA is not usually possible. We therefore modified a conventional W/O/W emulsion method by utilizing NH4Cl in the external phase to constrain DOX in dissolved polymer phase by suppressing DOX's inherent aqueous solubility as per common ion effect. This resulted in over 8-fold enhancement in entrapment efficiency of DOX inside BPNP, which otherwise is highly susceptible to leakage due to its relatively high aqueous solubility. TEM and DLS established BPNP to be sized below 100 nm, storage stability studies showed that BPNP were stable for one month at 4 °C, and in vitro release suggested significant control in drug release. Extensive in vitro and in vivo studies were conducted to propound anticancer and antiproliferative activity of BPNP. Plasma and tissue distribution study supplemented by pertinent in vivo fluorescence imaging mapped the exact fate of DOX contained inside BPNP once it was administered intravenously. A comparative safety profile via acute toxicity studies in mice was also generated to out rightly establish usefulness of BPNP. Results suggest that BPNP substantially enhance anticancer activity of DOX while simultaneously mitigating its toxic potential due to altered spatial and temporal presentation of drug and consequently deserve further allometric iteration.Entities:
Keywords: PLGA; active targeting; click chemistry; common ion effect; doxorubicin hydrochloride; nanoparticles
Mesh:
Substances:
Year: 2017 PMID: 28636400 DOI: 10.1021/acs.molpharmaceut.7b00310
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939